Year (12 month period from May 1 to April 30) | Patients entering into HIV care (n)* | Patients receiving first HIV VL test (n)† | Patients on ART (n)‡ | Percent HIV VL suppressed out of all VL tests§ |
2004–2005 | 118 829 | 27 937 | 24 208 | 31.1 |
2005–2006 | 219 942 | 111 865 | 120 796 | 39.4 |
2006–2007 | 302 510 | 176 979 | 272 078 | 43.4 |
2007–2008 | 344 935 | 223 188 | 420 542 | 50.3 |
2008–2009 | 410 563 | 283 929 | 609 729 | 55.4 |
2009–2010 | 479 406 | 249 971 | 716 555 | 65.7 |
2010–2011 | 915 898 | 525 457 | 1 066 016 | 72.3 |
2011–2012 | 713 101 | 582 175 | 1 465 428 | 72.2 |
2012–2013 | 626 296 | 672 543 | 1 875 968 | 74.0 |
2013–2014 | 619 396 | 715 786 | 2 316 959 | 74.6 |
2014–2015 | 629 246 | 785 503 | 2 801 889 | 77.1 |
2015–2016 | 666 492 | 952 256 | 3 429 148 | 79.6 |
2016–2017 | 629 754 | 919 229 | 3 951 406 | 79.4 |
2017–2018 | 461 076 | 913 604 | 4 419 017 | 83.2 |
*Numbers of patients into HIV care are the number of patients with a first CD4 or first VL.
†Number of patients receiving first HIV VL test is the number of first of VL tests.
‡Number of patients on ART is the number of patients who had a VL test in the 18-month period from 1 November (year–1) to 30 April (year+1).
§Per cent of HIV VL suppressed are 100×(the number of VL <400 cp/mL/total number of VL tests) during the same 18-month period. Patients who did not receive a VL test are not included.
ART, antiretroviral therapy; VL, viral load.